HS-20094

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for HS-20094, covering 2023-11-07 to 2026-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-20094 in Chinese Adults With Overweight or Obesity [Phase 3]